Format

Send to

Choose Destination
Curr Diab Rep. 2017 Sep 23;17(11):111. doi: 10.1007/s11892-017-0944-6.

Keeping Up with the Diabetes Technology: 2016 Endocrine Society Guidelines of Insulin Pump Therapy and Continuous Glucose Monitor Management of Diabetes.

Author information

1
Division of Pediatric Endocrinology and Diabetes, Yale School of Medicine, 333 Cedar St., P.O. Box 208064, New Haven, CT, 06520, USA.
2
Department of Women and Children's Health, University of Padova, Padova, Italy.
3
Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
4
Division of Pediatric Endocrinology and Diabetes, Yale School of Medicine, 333 Cedar St., P.O. Box 208064, New Haven, CT, 06520, USA. Eda.Cengiz@yale.edu.
5
Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA. Eda.Cengiz@yale.edu.
6
Division of Pediatric Endocrinology, Koc University School of Medicine, Istanbul, Turkey. Eda.Cengiz@yale.edu.

Abstract

PURPOSE OF REVIEW:

Decades after the invention of insulin pump, diabetes management has encountered a technology revolution with the introduction of continuous glucose monitoring, sensor-augmented insulin pump therapy and closed-loop/artificial pancreas systems. In this review, we discuss the significance of the 2016 Endocrine Society Guidelines for insulin pump therapy and continuous glucose monitoring and summarize findings from relevant diabetes technology studies that were conducted after the publication of the 2016 Endocrine Society Guidelines.

RECENT FINDINGS:

The 2016 Endocrine Society Guidelines have been a great resource for clinicians managing diabetes in this new era of diabetes technology. There is good body of evidence indicating that using diabetes technology systems safely tightens glycemic control while managing both type 1 and type 2 diabetes. The first-generation diabetes technology systems will evolve as we gain more experience and collaboratively work to improve them with an ultimate goal of keeping people with diabetes complication and burden-free until the cure for diabetes becomes a reality.

KEYWORDS:

Continuous glucose monitoring; Hybrid closed-loop; Insulin pump; Type 1 diabetes; Type 2 diabetes

PMID:
28942594
DOI:
10.1007/s11892-017-0944-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center